Bile acid malabsorption in inflammatory bowel disease: Assessment by serum markers

Inflammatory Bowel Diseases

Volumn 17, Issue 6, 2011, Pages 1322-1327

  Lenicek, Martin ^a   Duricova, Dana ^b   Komarek, Viktor ^b   Gabrysova, Bronislava ^a   Lukas, Milan ^a   Smerhovsky, Zdenek ^a,c   Vitek, Libor ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b ISCARE IVF   (Czech Republic)

^c NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

Author keywords

7 hydroxycholest 4 en 3 one; bile acid malabsorption; Crohn's disease; ileal disease; inflammatory bowel disease

Indexed keywords

7ALPHA HYDROXYCHOLEST 4 EN 3 ONE; BILE ACID; BIOLOGICAL MARKER; CHOLESTEROL; FIBROBLAST GROWTH FACTOR 19; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BILE ACID MALABSORPTION; BLOOD CHEMISTRY; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CROHN DISEASE; FEMALE; HEALTH SURVEY; HUMAN; ILEITIS; ILEUM RESECTION; MAJOR CLINICAL STUDY; MALABSORPTION; MALE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADULT; BILE ACIDS AND SALTS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHOLESTEROL; CHOLESTEROL, HDL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLITIS, ULCERATIVE; CROHN DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; INFLAMMATORY BOWEL DISEASES; MALABSORPTION SYNDROMES; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 79955877884     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21502     Document Type: Article

References (33)

1. Carey MC, Duane WC., Enterohepatic Circulation. In:, Arias IM, Boyer JL, Fausto N, et al, eds. The Liver: Biology and Pathobiology. Raven Press Ltd.: New York; 1994: 719-767.
2. Chadwick VS, Modha K, Dowling RH., Mechanism for hyperoxaluria in patients with ileal dysfunction. N Engl J Med. 1973; 289: 172-176.
3. Vitek L, Carey MC., Enterohepatic cycling of bilirubin as a cause of 'black' pigment gallstones in adult life. Eur J Clin Invest. 2003; 33: 799-810. (Pubitemid 37082867)
4. Puleston J, Morgan H, Andreyev J., New treatment for bile salt malabsorption. Gut. 2005; 54: 441-444a.
5. Caspary WF, Tonissen J, Lankisch PG., 'Enteral' hyperoxaluria. Effect of cholestyramine, calcium, neomycin, and bile acids on intestinal oxalate absorption in man. Acta Hepatogastroenterol. 1977; 24: 193-200. (Pubitemid 8132445)
6. Laker MF, Hofmann AF., Effective therapy of enteric hyperoxaluria: in vitro binding of oxalate by anion-exchange resins and aluminum hydroxide. J Pharm Sci. 1981; 70: 1065-1067. (Pubitemid 11011436)
7. Pak CY, Sakhaee K, Fuller CJ., Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy. Trans Assoc Am Physicians. 1983; 96: 294-305.
8. Miettinen TA., Relationship between fecal bile acids, absorption of fat and vitamin B12, and serum lipids in patients with ileal resections. Eur J Clin Invest. 1971; 1: 452-460.
9. Fromm H, Malavolti M., Bile acid-induced diarrhoea. Clin Gastroenterol. 1986; 15: 567-582. (Pubitemid 16009181)
10. Eusufzai S, Axelson M, Angelin B, et al. Serum 7 alpha-hydroxy-4- cholesten-3-one concentrations in the evaluation of bile acid malabsorption in patients with diarrhoea: correlation to SeHCAT test. Gut. 1993; 34: 698-701. (Pubitemid 23146900)
11. Sauter GH, Munzing W, Ritter CV, et al. Bile acid malabsorption as a cause of chronic diarrhea. Diagnostic value of 7alpha-hydroxy-4-cholesten-3-one in serum. Dig Dis Sci. 1999; 44: 14-19. (Pubitemid 29053072)
12. Williams AJ, Merrick MV, Eastwood MA., Idiopathic bile acid malabsorption-a review of clinical presentation, diagnosis, and response to treatment. Gut. 1991; 32: 1004-1006.
13. Ung KA, Gillberg R, Kilander A, et al. Role of bile acids and bile acid binding agents in patients with collagenous colitis. Gut. 2000; 46: 170-175. (Pubitemid 30305841)
14. Fernandez-Banares F, Esteve M, Salas A, et al. Bile acid malabsorption in microscopic colitis and in previously unexplained functional chronic diarrhea. Dig Dis Sci. 2001; 46: 2231-2238. (Pubitemid 32955237)
15. Smith MJ, Cherian P, Raju GS, et al. Bile acid malabsorption in persistent diarrhoea. J R Coll Physicians Lond. 2000; 34: 448-451.
16. Nyhlin H, Merrick MV, Eastwood MA., Bile acid malabsorption in Crohn's disease and indications for its assessment using SeHCAT. Gut. 1994; 35: 90-93. (Pubitemid 24059479)
17. Otte JJ, Andersen JR., The clinical value of faecal bile acid determination in patients with chronic diarrhoea of unknown origin. Scand J Gastroenterol. 1986; 21: 585-588. (Pubitemid 16085649)
18. Scarpello JHB, Sladen GE., 12C-glycocholate test in Crohn's disease its value in assessment and treatment. Gut. 1977; 18: 736-741. (Pubitemid 8196471)
19. Craddock AL, Love MW, Daniel RW, et al. Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter. Am J Physiol. 1998; 274: G157-G169.
20. Dietschy JM., Mechanisms for the intestinal absorption of bile acids. J Lipid Res. 1968; 9: 297-309.
21. Renner O, Harsch S, Schaeffeler E, et al. Mutation screening of apical sodium-dependent bile acid transporter (SLC10A2): novel haplotype block including six newly identified variants linked to reduced expression. Hum Genet. 2009; 125: 381-391.
22. Holt JA, Luo G, Billin AN, et al. Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. Genes Dev. 2003; 17: 1581-1591. (Pubitemid 36828786)
23. Walters JR, Tasleem AM, Omer OS, et al. A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis. Clin Gastroenterol Hepatol. 2009; 7: 1189-1194.
24. Hofmann AF, Mangelsdorf DJ, Kliewer SA., Chronic diarrhea due to excessive bile acid synthesis and not defective ileal transport: a new syndrome of defective fibroblast growth factor 19 release. Clin Gastroenterol Hepatol. 2009; 7: 1151-1154.
25. Kovar J, Lenicek M, Zimolova M, et al. Regulation of diurnal variation of cholesterol 7 alpha-hydroxylase (CYP7A1) activity in healthy subjects. Phys Res. 2010; 59: 233-238.
26. Galman C, Angelin B, Rudling M., Bile acid synthesis in humans has a rapid diurnal variation that is asynchronous with cholesterol synthesis. Gastroenterology. 2005; 129: 1445-1453. (Pubitemid 41597387)
27. Lenicek M, Juklova M, Zelenka J, et al. Improved HPLC analysis of serum 7{alpha}-hydroxycholest-4-en-3-one, a marker of bile acid malabsorption. Clin Chem. 2008; 54: 1087-1088. (Pubitemid 351793419)
28. Honda A, Yoshida T, Xu G, et al. Significance of plasma 7alpha-hydroxy-4-cholesten-3-one and 27-hydroxycholesterol concentrations as markers for hepatic bile acid synthesis in cholesterol-fed rabbits. Metabolism. 2004; 53: 42-48. (Pubitemid 38071934)
29. Lenicek M, Komarek V, Zimolova M, et al. CYP7A1 promoter polymorphism -203A>C affects bile salt synthesis rate in patients after ileal resection. J Lipid Res. 2008; 49: 2664-2667.
30. Bajor A, Kilander A, Fae A, et al. Normal or increased bile acid uptake in isolated mucosa from patients with bile acid malabsorption. Eur J Gastroenterol Hepatol. 2006; 18: 397-403.
31. Jung D, Fantin AC, Scheurer U, et al. Human ileal bile acid transporter gene ASBT (SLC10A2) is transactivated by the glucocorticoid receptor. Gut. 2004; 53: 78-84. (Pubitemid 38083014)
32. Holzer A, Harsch S, Renner O, et al. Diminished expression of apical sodium-dependent bile acid transporter in gallstone disease is independent of ileal inflammation. Digestion. 2008; 78: 52-59.
33. Odunsi-Shiyanbade ST, Camilleri M, McKinzie S, et al. Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function. Clin Gastroenterol Hepatol. 2010; 8: 159-165.